189 related articles for article (PubMed ID: 20026215)
21. Resistance to antibacterial antifolates in multidrug-resistant Staphylococcus aureus: prevalence estimates and genetic basis.
Kime L; Waring T; Mohamad M; Mann BF; O'Neill AJ
J Antimicrob Chemother; 2023 May; 78(5):1201-1210. PubMed ID: 36935372
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the gene for chromosomal trimethoprim-sensitive dihydrofolate reductase of Staphylococcus aureus ATCC 25923.
Dale GE; Then RL; Stüber D
Antimicrob Agents Chemother; 1993 Jul; 37(7):1400-5. PubMed ID: 8363365
[TBL] [Abstract][Full Text] [Related]
23. Plasmid-mediated trimethoprim-resistance in Staphylococcus aureus. Characterization of the first gram-positive plasmid dihydrofolate reductase (type S1).
Young HK; Skurray RA; Amyes SG
Biochem J; 1987 Apr; 243(1):309-12. PubMed ID: 3606580
[TBL] [Abstract][Full Text] [Related]
24. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques.
Vickers AA; Potter NJ; Fishwick CW; Chopra I; O'Neill AJ
J Antimicrob Chemother; 2009 Jun; 63(6):1112-7. PubMed ID: 19383727
[TBL] [Abstract][Full Text] [Related]
25. Improving protein solubility through rationally designed amino acid replacements: solubilization of the trimethoprim-resistant type S1 dihydrofolate reductase.
Dale GE; Broger C; Langen H; D'Arcy A; Stüber D
Protein Eng; 1994 Jul; 7(7):933-9. PubMed ID: 7971955
[TBL] [Abstract][Full Text] [Related]
26. Reduced susceptibility of Moritella profunda dihydrofolate reductase to trimethoprim is not due to glutamate 28.
Loveridge EJ; Dawson WM; Evans RM; Sobolewska A; Allemann RK
Protein J; 2011 Dec; 30(8):546-8. PubMed ID: 21968646
[TBL] [Abstract][Full Text] [Related]
27. Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae.
Adrian PV; Klugman KP
Antimicrob Agents Chemother; 1997 Nov; 41(11):2406-13. PubMed ID: 9371341
[TBL] [Abstract][Full Text] [Related]
28. Towards new antifolates targeting eukaryotic opportunistic infections.
Liu J; Bolstad DB; Bolstad ES; Wright DL; Anderson AC
Eukaryot Cell; 2009 Apr; 8(4):483-6. PubMed ID: 19168759
[TBL] [Abstract][Full Text] [Related]
29. Cloning and characterization of a novel, plasmid-encoded trimethoprim-resistant dihydrofolate reductase from Staphylococcus haemolyticus MUR313.
Dale GE; Langen H; Page MG; Then RL; Stüber D
Antimicrob Agents Chemother; 1995 Sep; 39(9):1920-4. PubMed ID: 8540692
[TBL] [Abstract][Full Text] [Related]
30. Increased solubility of trimethoprim-resistant type S1 DHFR from Staphylococcus aureus in Escherichia coli cells overproducing the chaperonins GroEL and GroES.
Dale GE; Schönfeld HJ; Langen H; Stieger M
Protein Eng; 1994 Jul; 7(7):925-31. PubMed ID: 7971954
[TBL] [Abstract][Full Text] [Related]
31. A plasmid-encoded dihydrofolate reductase from trimethoprim-resistant bacteria has a novel D2-symmetric active site.
Narayana N; Matthews DA; Howell EE; Nguyen-huu X
Nat Struct Biol; 1995 Nov; 2(11):1018-25. PubMed ID: 7583655
[TBL] [Abstract][Full Text] [Related]
32. Trypanosomal dihydrofolate reductase reveals natural antifolate resistance.
Vanichtanankul J; Taweechai S; Yuvaniyama J; Vilaivan T; Chitnumsub P; Kamchonwongpaisan S; Yuthavong Y
ACS Chem Biol; 2011 Sep; 6(9):905-11. PubMed ID: 21650210
[TBL] [Abstract][Full Text] [Related]
33. Trimethoprim and brodimoprim resistance of gram-positive and gram-negative bacteria.
Thomson CJ
J Chemother; 1993 Dec; 5(6):458-64. PubMed ID: 8195838
[TBL] [Abstract][Full Text] [Related]
34. Frequency and transferability of trimethoprim and sulfonamide resistance in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Then RL; Kohl I; Burdeska A
J Chemother; 1992 Apr; 4(2):67-71. PubMed ID: 1629749
[TBL] [Abstract][Full Text] [Related]
35. A trimethoprim derivative impedes antibiotic resistance evolution.
Manna MS; Tamer YT; Gaszek I; Poulides N; Ahmed A; Wang X; Toprak FCR; Woodard DR; Koh AY; Williams NS; Borek D; Atilgan AR; Hulleman JD; Atilgan C; Tambar U; Toprak E
Nat Commun; 2021 May; 12(1):2949. PubMed ID: 34011959
[TBL] [Abstract][Full Text] [Related]
36. Trade-offs with stability modulate innate and mutationally acquired drug resistance in bacterial dihydrofolate reductase enzymes.
Matange N; Bodkhe S; Patel M; Shah P
Biochem J; 2018 Jun; 475(12):2107-2125. PubMed ID: 29871875
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of Resistance to Folate Pathway Inhibitors in
Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
[TBL] [Abstract][Full Text] [Related]
38. 2,4-Diamino-5-(2'-arylpropargyl)pyrimidine derivatives as new nonclassical antifolates for human dihydrofolate reductase inhibition.
Algul O; Paulsen JL; Anderson AC
J Mol Graph Model; 2011 Feb; 29(5):608-13. PubMed ID: 21146434
[TBL] [Abstract][Full Text] [Related]
39. Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors.
Wróbel A; Arciszewska K; Maliszewski D; Drozdowska D
J Antibiot (Tokyo); 2020 Jan; 73(1):5-27. PubMed ID: 31578455
[TBL] [Abstract][Full Text] [Related]
40. Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim.
Barrow EW; Bourne PC; Barrow WW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4643-9. PubMed ID: 15561838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
